http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002179562-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5859836cd5b65a17aa0963b145287c90
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
filingDate 2000-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fecc7203f276ef2eb83735cb4bf231f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_826a89ed664498a0b3d105843c1c5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c851854c1d47f0fb85cf42592eb77663
publicationDate 2002-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2002179562-A
titleOfInvention Stable intravenous painless propofol fat emulsion
abstract PROBLEM TO BE SOLVED: To improve the storage stability of a fat emulsion containing lidocaine in order to reduce vascular pain upon injection, which is a side effect of intravenous propofol fat emulsion. SOLUTION: Lidocaine is added in advance to an oil phase component containing prophor, and this is emulsified in water to obtain an emulsion. A surfactant having an HLB of 10 or more is added as a stabilizer to the aqueous phase in advance, or added later to the emulsion, and the pH of the emulsion is adjusted to 3.0 to 3.0 in the presence of the stabilizer. Adjust to a range of 6.5.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100367943-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1875901-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2004052354-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2006112276-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1704858-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1704858-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004052354-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1875901-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006112276-A1
priorityDate 2000-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415746871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454185321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448300745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22483

Total number of triples: 45.